FEATURED NEWS

Office of the Gene Technology Regulator stonewalls questions about the vaccine

Another masterclass in deception and deflecting.

The Office of Gene Technology says is it only responsible for Gene Therapy but can’t answer what Gene Technology is even though it’s the Office of Gene Technology.

You can’t make this stuff up.

••••••••••••••••••••••••••••••••

“Are you familiar with endogenous reverse transcriptase?

About 8% of the humane genome can reverse mRNA back into DNA?

That question has already been answered on notice Senator.

Are you familiar with it? Are you aware of it?

No, familiar with what sorry?

You’re not familiar with it?

We’ve responded to that question on Notice.

I’m aware of that but I just want to look you in the eye and have this conversation now.

I’m asking if you’re familiar with it and the risks that are associated with it?

In what context Senator?

Well the context that the mRNA gets produced inside the cytoplasm and then the reverse transcriptase can convert the mRNA back into DNA.

That has been observed but in terms of your question you would have to put some context around it.

It’s been observed? Well can you put some context around that statement?

NOW FOR THE DEFLECTION FROM THE CHAIR ACTING ON INSTRUCTIONS OVER THE PHONE. THE CHAIR DOESN’T HAVE TO FOLLOW ALL SHE HAS TO DO IS CHAIR.

Senator I’m not following at this point.”

••••••••••••••••••••••••••••••••••

In this set of questions I asked about the plasmids in the vaccine and the risk that naturally occurring enzymes can convert mRNA back into DNA.

Both times the bureaucracy responded with they’ve answered the question on notice.

The question to do with the SV40 promoter was answered by saying the Office of Gene Technology isn’t responsible for it so it wasn’t an answer.

This is the typical deflection the bureaucracy keeps giving to hide their crimes.

Further reading:
https://www.science.org/content/blog-post/integration-human-genome

https://www.pfizer.com/science/innovation/gene-therapy/manufacturing

Community Affairs Legislation Committee
05/06/2024
Estimates
HEALTH AND AGED CARE PORTFOLIO
Office of the Gene Technology

Senator RENNICK: I know you keep saying that the COVID vaccines are not gene therapy. But both Pfizer and Moderna have made statements to say that the vaccines were gene therapy. How do you reconcile the conflicting statements?

Dr Bhula : Which information is it that you’re referring to in terms of Pfizer and Moderna?

Senator RENNICK: Moderna said it in their financial filing, their SEC filing. It’s mentioned. They referred to gene therapy. Pfizer have said it and I’ve tabled it in the past. They referred to the actual gene section as gene therapy.

Dr Bhula : As I’ve just explained to Senator Roberts, gene therapies generally are therapies that are used for treatments of rare genetic diseases and heritable disorders. Gene therapies, when introduced into a patient, kickstart a defect or genetic disorder that exists within that patient. An example is something like haemophilia, which is a heritable disease. When the gene therapy is administered into a haemophilia patient, it allows the patient to produce blood clotting factor, which they wouldn’t be able to do without the therapy, which alleviates the conditions of haemophilia such as bleeding out. That’s what a gene therapy is.

Senator RENNICK: That’s not what you told me in the past. In the past you told me it’s something that targets the nucleus. I’ll note that Pfizer uses an SV40 promoter in the E. coli, that I just discussed, that actually targets the nucleus.

Dr Bhula : The SV40 promoter question we’ve already responded to on notice. That’s SQ23002094.

Senator RENNICK: I’m aware of that, but I’m just saying that what you just said then contradicts your prior advice. I thought you defined gene technology as going into the nucleus, as opposed to cytoplasm.

Dr Bhula : The question was about gene therapy.

Senator RENNICK: That’s what you defined gene therapy as in the past.

Dr Bhula : You referred to gene technology just before.

Senator RENNICK: Gene therapy, gene technology—I use the two interchangeably.

Dr Bhula : They’re different things.

Senator RENNICK: So what were you referring to?

Dr Bhula : Your question was about gene therapy, and I just answered Senator Roberts’ question about gene therapy.

Senator RENNICK: So you’re not saying that the COVID-19 is about gene therapy?

Dr Bhula : The COVID-19 vaccines are not gene therapies.

Senator RENNICK: So do you consider it gene technology?

Dr Bhula : Consider what as gene technology?

Senator RENNICK: You’re the one that’s made the distinction between the two. I would have thought they were similar. I think I know what I’m talking about.

CHAIR: I think they’re two different things under discussion here, Senator.

Senator RENNICK: On retroposition, are you familiar with endogenous reverse transcriptase? It’s about 80 per cent of the genome and actually enzymes that convert mRNA back into DNA.

Dr Bhula : That question has already been answered on notice.

Senator RENNICK: Are you familiar with it? Are you aware of it?

Dr Bhula : Am I familiar with what, sorry?

Senator RENNICK: You’re not familiar with it?

Dr Bhula : We’ve responded to that question on notice.

Senator RENNICK: I’m aware of that, but I just want to look you in the eye and have this conversation now. Are you familiar with it? I’m asking if you’re familiar with it and the risks that are associated with it.

Dr Bhula : In what context?

Senator RENNICK: The context that the mRNA gets produced inside the cytoplasm, and then the reverse transcriptase can reverse that mRNA back into DNA, hence the reverse transcriptase.

Dr Bhula : That has been observed, but in terms of your question you would have to put some context around it.

Senator RENNICK: Well, it has been observed, so can you put context around that statement?

CHAIR: I’m not following at this point.

Senator RENNICK: They’re the Office of the Gene Technology Regulator. It is to do with the risk of mRNA being converted back into DNA so it goes from the cytoplasm back into the nucleus. We’re told that’s not supposed to happen, but they haven’t done any genotoxicity studies to prove that the endogenous reverse transcriptase doesn’t transform that mRNA back into DNA. That’s the question I’m asking you.

Dr Bhula : As we’ve said on a number of occasions, the mRNA COVID-19 vaccines, as produced by Pfizer and Moderna, were approved through the TGA. They do not require an authorisation through the OGTR because they do not contain genetically modified organisms.

CHAIR: I’m in no way asking you to stop your line of questioning, Senator Rennick, but I know that you both want to get to the National Blood Authority. I don’t want you to miss out.

Thank you very much.

Share:

Facebook
Twitter
Pinterest
LinkedIn

SENATE SPEECHES

THE ISSUES

Click on an interest area to read articles and learn more about the work I am doing in Parliament.

Taxation, Finance & Economy

READ MORE

Education & Family

READ MORE

Energy

READ MORE

Environment

READ MORE

Health, Aged Care & Seniors

READ MORE

Primary Industries

READ MORE

Immigration & Foreign Affairs

READ MORE

Infrastructure, Manufacturing, Transport & Tourism

READ MORE

Defence

READ MORE

Federation Reform

READ MORE

I may get kicked off social media soon for speaking too much truth so please join my mailing list so we can always stay in touch...

Thank you,

Gerard